CREB1 and melanoma: The post-translational modifications of endogenous ICER, or the N-terminal HA-tagged ICER in this model, permit promoter CRE binding of CREB, which further stimulates PKA activity, and may partially explain the resurgence of phosphorylated CREB in drug-resistant melanoma.